Maria Rivas - Cooper Companies Independent Director
| COO Stock | USD 80.10 0.82 1.01% |
Director
Maria Rivas is Independent Director of The Cooper Companies since 2021.
| Age | 57 |
| Tenure | 5 years |
| Address | 6101 Bollinger Canyon Road, San Ramon, CA, United States, 94583 |
| Phone | 925 460 3600 |
| Web | https://www.coopercos.com |
Latest Insider Transactions
Cooper Companies Management Efficiency
The company has Return on Asset of 0.0347 % which means that on every $100 spent on assets, it made $0.0347 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0459 %, implying that it generated $0.0459 on every 100 dollars invested. Cooper Companies' management efficiency ratios could be used to measure how well Cooper Companies manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Cooper Companies' Return On Tangible Assets are very stable compared to the past year. As of the 5th of February 2026, Return On Equity is likely to grow to 0.04, while Return On Capital Employed is likely to drop 0.05. At this time, Cooper Companies' Other Assets are very stable compared to the past year. As of the 5th of February 2026, Net Tangible Assets is likely to grow to about 2.7 B, while Intangibles To Total Assets are likely to drop 0.32.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Angie Risley | Smith Nephew SNATS | 62 | |
| AnneFrancoise Nesmes | Smith Nephew SNATS | 53 | |
| Warren Nimetz | Universal Health Services | 64 | |
| Manmeet Soni | Summit Therapeutics PLC | 46 | |
| Elliot Sussman | Universal Health Services | 68 | |
| Erik Engstrom | Smith Nephew SNATS | 57 | |
| John Rogers | Smith Nephew SNATS | 57 | |
| Maria Singer | Universal Health Services | 46 | |
| Lawrence Gibbs | Universal Health Services | 48 | |
| Robin Freestone | Smith Nephew SNATS | 61 | |
| Katarzyna MazurHofsaess | Smith Nephew SNATS | 57 | |
| Marc Owen | Smith Nephew SNATS | 61 | |
| Vinita Bali | Smith Nephew SNATS | 63 | |
| John Ma | Smith Nephew SNATS | 58 | |
| Rick Medlock | Smith Nephew SNATS | 60 | |
| Virginia Bottomley | Smith Nephew SNATS | 72 | |
| Bob White | Smith Nephew SNATS | 58 | |
| Eileen McDonnell | Universal Health Services | 57 | |
Management Performance
| Return On Equity | 0.0459 | ||||
| Return On Asset | 0.0347 |
Cooper Companies Leadership Team
Elected by the shareholders, the Cooper Companies' board of directors comprises two types of representatives: Cooper Companies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cooper. The board's role is to monitor Cooper Companies' management team and ensure that shareholders' interests are well served. Cooper Companies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cooper Companies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Nicholas JD, General Secretary | ||
| Robert Weiss, CEO and President Non-Independent Director and Member of Science and Technology Committee | ||
| Teresa Madden, Independent Director | ||
| Holly Sheffield, Executive Vice President and Chief Strategy Officer | ||
| Kim Duncan, Senior Director - Investor Relations | ||
| Agostino Ricupati, Senior Vice President - Finance and Tax, Chief Accounting Officer | ||
| Mark Drury, Vice President General Counsel, Secretary | ||
| Gerard III, I CooperVision | ||
| A Bender, Independent Chairman of the Board | ||
| Daniel McBride, Chief Operating Officer, Executive Vice President, President of CooperVision, Inc. | ||
| Maria Rivas, Independent Director | ||
| Albert White, President, Chief Executive Officer, Director | ||
| Juan Aragon, Pres Division | ||
| Albert III, CEO President | ||
| Allan Rubenstein, Independent Vice Chairman of the Board, Lead Director | ||
| William Kozy, Lead Independent Director | ||
| Randal Golden, Vice President, General Counsel, Secretary | ||
| Robert Auerbach, President - CooperSurgical | ||
| Warner H, President CooperVision, Inc | ||
| Gary Petersmeyer, Independent Director | ||
| Daniel Esq, Executive COO | ||
| Agostino CPA, Senior Officer | ||
| Jody Lindell, Independent Director | ||
| Colleen Jay, Independent Director | ||
| Nicholas Khadder, General Secretary | ||
| Brian Andrews, Chief Financial Officer, Executive Vice President, Treasurer |
Cooper Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cooper Companies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0459 | ||||
| Return On Asset | 0.0347 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.14 % | ||||
| Current Valuation | 18.2 B | ||||
| Shares Outstanding | 195.98 M | ||||
| Shares Owned By Insiders | 0.62 % | ||||
| Shares Owned By Institutions | 99.38 % | ||||
| Number Of Shares Shorted | 7.24 M | ||||
| Price To Earning | 35.89 X |
Pair Trading with Cooper Companies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cooper Companies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cooper Companies will appreciate offsetting losses from the drop in the long position's value.Moving against Cooper Stock
| 0.94 | OTC | Ocumetics Technology Corp | PairCorr |
| 0.93 | IVF | INVO Fertility Symbol Change | PairCorr |
| 0.84 | AHC | Austco Healthcare | PairCorr |
| 0.84 | IHC | Inspiration Healthcare | PairCorr |
| 0.52 | AHG | Akso Health Group | PairCorr |
The ability to find closely correlated positions to Cooper Companies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cooper Companies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cooper Companies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling The Cooper Companies to buy it.
The correlation of Cooper Companies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cooper Companies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cooper Companies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cooper Companies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in The Cooper Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Will Health Care Equipment & Supplies sector continue expanding? Could Cooper diversify its offerings? Factors like these will boost the valuation of Cooper Companies. Projected growth potential of Cooper fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Cooper Companies data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.28) | Earnings Share 1.91 | Revenue Per Share | Quarterly Revenue Growth 0.046 | Return On Assets |
Investors evaluate Cooper Companies using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Cooper Companies' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Cooper Companies' market price to deviate significantly from intrinsic value.
It's important to distinguish between Cooper Companies' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cooper Companies should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Cooper Companies' market price signifies the transaction level at which participants voluntarily complete trades.